Literature DB >> 2523979

Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.

J Brandt1, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian.   

Abstract

Clinical medicine in the 21st century is almost certain to include wide-scale use of molecular genetic diagnostic tests. In September 1986, The Johns Hopkins University School of Medicine initiated a voluntary program of presymptomatic genetic testing for Huntington's disease for persons at 50% risk. DNA analyses using the D4S10 (G8), D4S43, and D4S95 locus probes have been performed for 55 people. Twelve of the tests have yielded positive results, 30 were negative, and 13 were uninformative. Initial reactions ranged from joy and relief to disappointment, sadness, and demoralization. Thus far, there have been no severe depressive reactions. Although the sample size is small, our data suggest that people who receive genetic test results cope well, at least over the short term, when the testing is performed in a clinical context that includes education, pretest counseling, psychological support, and regular follow-up.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523979

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

Review 2.  Huntington disease and the abuse of genetics.

Authors:  P S Harper
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

3.  Discrimination as a consequence of genetic testing.

Authors:  P R Billings; M A Kohn; M de Cuevas; J Beckwith; J S Alper; M R Natowicz
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

4.  Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.

Authors:  K Lawson; S Wiggins; T Green; S Adam; M Bloch; M R Hayden
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

5.  Offering predictive testing for Huntington disease in a medical genetics clinic: Practical applications.

Authors:  R L Bennett; T D Bird; L Teri
Journal:  J Genet Couns       Date:  1993-09       Impact factor: 2.537

6.  Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.

Authors:  A C DudokdeWit; A Tibben; H J Duivenvoorden; M F Niermeijer; J Passchier
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

Review 7.  Genetic testing for Huntington's disease.

Authors:  P S Harper; M J Morris; A Tyler
Journal:  BMJ       Date:  1990-04-28

8.  Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation.

Authors:  J R Campodonico; A M Codori; J Brandt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

9.  Presymptomatic Diagnosis of Genetic Disorders: Is it worth the anxiety?

Authors:  T N Tannenbaum; E E Rosenberg
Journal:  Can Fam Physician       Date:  1991-02       Impact factor: 3.275

Review 10.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.